Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) EPS (Basic) (2016 - 2026)

Usana Health Sciences (USNA) has disclosed EPS (Basic) for 17 consecutive years, with -$0.09 as the latest value for Q1 2026.

  • Quarterly EPS (Basic) fell 139.13% to -$0.09 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $0.56 through Jan 2026, down 74.55% year-over-year, with the annual reading at $0.58 for FY2026, 73.64% down from the prior year.
  • EPS (Basic) for Q1 2026 was -$0.09 at Usana Health Sciences, up from -$0.36 in the prior quarter.
  • The five-year high for EPS (Basic) was $1.77 in Q1 2022, with the low at -$0.36 in Q3 2025.
  • Average EPS (Basic) over 5 years is $0.67, with a median of $0.66 recorded in 2022.
  • The sharpest move saw EPS (Basic) soared 31.82% in 2023, then crashed 164.29% in 2025.
  • Over 5 years, EPS (Basic) stood at $0.66 in 2022, then soared by 31.82% to $0.87 in 2023, then tumbled by 73.56% to $0.23 in 2024, then plummeted by 256.52% to -$0.36 in 2025, then soared by 75.0% to -$0.09 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.09, -$0.36, and $0.52 for Q1 2026, Q3 2025, and Q2 2025 respectively.